您的位置: 首页 > 农业专利 > 详情页

High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
专利权人:
Nantomics, LLC;Nantomics; LLC;Nant Holdings IP, LLC
发明人:
Nguyen, Andrew,Sanborn, John Zachary,Benz, Stephen Charles,Niazi, Kayvan,Rabizadeh, Shahrooz,Soon-Shiong, Patrick,Vaske, Charles Joseph
申请号:
AU2017217877
公开号:
AU2017217877A1
申请日:
2017.02.10
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Systems and methods are presented that allow for selection of tumor neoepitopes that are filtered for various criteria. In particularly contemplated aspects, filtering includes a step in which the mutation leading to the neoepitope is ascertained as being located in a cancer driver gene.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充